Compare Stocks

Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities.

Comparative Price Performance Over Time

Compare Price & Volume

Company	Current Price	50-Day Moving Average	52-Week Range	Market Cap	Beta	Avg. Volume	Today's Volume
GH Guardant Health	$61.40 +0.2%	$50.26	$20.14 ▼ $62.81	$7.64B	1.43	3.32 million shs	2.00 million shs
HIMS Hims & Hers Health	$44.53 +1.3%	$51.71	$13.47 ▼ $72.98	$10.07B	2.08	34.22 million shs	27.93 million shs
RDNT RadNet	$70.10 +2.2%	$58.44	$45.00 ▼ $93.65	$5.28B	1.43	1.02 million shs	700,892 shs
SGRY Surgery Partners	$23.64 +3.4%	$22.13	$18.87 ▼ $33.97	$2.93B	1.82	1.78 million shs	1.27 million shs

Ten Starter Stocks For Beginners to Buy Now

Just getting into the stock market? These 10 simple stocks can help beginning investors build long-term wealth without knowing options, technicals, or other advanced strategies.

Get This Free Report

Compare Price Performance

Company	1-Day Performance	7-Day Performance	30-Day Performance	90-Day Performance	1-Year Performance
GH Guardant Health	+0.20%	+4.28%	+35.09%	+61.58%	+117.27%
HIMS Hims & Hers Health	+1.65%	-3.38%	-23.23%	-18.87%	+168.90%
RDNT RadNet	+2.17%	+3.93%	+19.75%	+23.83%	+11.02%
SGRY Surgery Partners	+3.41%	+3.68%	+6.39%	+3.68%	-15.36%

Compare MarketRank™

Company	Overall Score	Analyst's Opinion	Short Interest Score	ESG Score	News and Social Media Sentiment	Company Ownership	Earnings & Valuation
GH Guardant Health	3.2201 of 5 stars	1.5	2.0	4.4	2.8	2.5	0.6
HIMS Hims & Hers Health	2.7894 of 5 stars	2.0	3.0	0.0	2.9	3.3	1.9
RDNT RadNet	3.281 of 5 stars	1.6	2.0	4.6	3.9	2.5	0.0
SGRY Surgery Partners	2.9888 of 5 stars	3.3	1.0	0.0	2.8	0.8	2.5

Compare Analyst Forecasts

Company	Consensus Rating Score	Consensus Rating	Consensus Price Target	% Upside from Current Price
GH Guardant Health	3.06	Buy	$57.50	-6.35% Downside
HIMS Hims & Hers Health	1.92	Reduce	$38.92	-12.61% Downside
RDNT RadNet	3.25	Buy	$71.60	2.14% Upside
SGRY Surgery Partners	2.67	Moderate Buy	$33.00	39.59% Upside

Current Analyst Ratings Breakdown

Latest SGRY, HIMS, GH, and RDNT Analyst Ratings

Date	Company	Brokerage	Action	Rating	Price Target
8/19/2025	HIMS Hims & Hers Health	Zacks Research Subscribe to MarketBeat All Access for the recommendation accuracy rating	Downgrade	Strong-Buy ➝ Hold
8/18/2025	HIMS Hims & Hers Health	Truist Financial Subscribe to MarketBeat All Access for the recommendation accuracy rating	Lower Price Target	Hold ➝ Hold	$48.00 ➝ $37.00
8/18/2025	RDNT RadNet	Zacks Research Subscribe to MarketBeat All Access for the recommendation accuracy rating	Upgrade	Strong Sell ➝ Hold
8/13/2025	RDNT RadNet	Raymond James Financial Subscribe to MarketBeat All Access for the recommendation accuracy rating	Reiterated Rating	Strong-Buy ➝ Strong-Buy	$66.00 ➝ $75.00
8/11/2025	RDNT RadNet	Morgan Stanley Subscribe to MarketBeat All Access for the recommendation accuracy rating	Upgrade	Overweight
8/5/2025	HIMS Hims & Hers Health	Needham & Company LLC Subscribe to MarketBeat All Access for the recommendation accuracy rating	Reiterated Rating	Hold ➝ Hold
7/31/2025	GH Guardant Health	Scotiabank Subscribe to MarketBeat All Access for the recommendation accuracy rating	Boost Price Target	Sector Outperform ➝ Sector Outperform	$57.00 ➝ $60.00
7/31/2025	GH Guardant Health	Raymond James Financial Subscribe to MarketBeat All Access for the recommendation accuracy rating	Boost Price Target	Outperform ➝ Outperform	$59.00 ➝ $61.00
7/28/2025	SGRY Surgery Partners	Bank of America Subscribe to MarketBeat All Access for the recommendation accuracy rating	Initiated Coverage	Buy	$28.00
7/17/2025	HIMS Hims & Hers Health	Truist Financial Subscribe to MarketBeat All Access for the recommendation accuracy rating	Boost Price Target	Hold ➝ Hold	$45.00 ➝ $48.00
7/14/2025	GH Guardant Health	Evercore ISI Subscribe to MarketBeat All Access for the recommendation accuracy rating	Upgrade	Strong-Buy

(Data available from 8/23/2022 forward. View 10+ years of historical ratings with our analyst ratings screener.)

Compare Sales & Book Value

Company	Annual Revenue	Price/Sales	Cashflow	Price/Cash	Book Value	Price/Book
GH Guardant Health	$828.85M	9.24	N/A	N/A	($2.45) per share	-25.06
HIMS Hims & Hers Health	$2.01B	5.00	$0.36 per share	124.83	$2.49 per share	17.88
RDNT RadNet	$1.83B	2.95	$3.56 per share	19.70	$15.33 per share	4.57
SGRY Surgery Partners	$3.11B	0.97	$1.94 per share	12.20	$24.62 per share	0.96

Compare Profitability & Earnings

Company	Net Income	EPS	Trailing P/E Ratio	Forward P/E Ratio	P/E Growth	Net Margins	Return on Equity (ROE)	Return on Assets (ROA)	Next Earnings Date
GH Guardant Health	-$436.37M	-$3.35	N/A	N/A	N/A	-49.93%	N/A	-28.95%	11/5/2025 (Estimated)
HIMS Hims & Hers Health	$126.04M	$0.80	55.66	85.63	2.97	9.63%	26.26%	13.06%	11/3/2025 (Estimated)
RDNT RadNet	$2.79M	-$0.20	N/A	132.26	N/A	-0.78%	2.41%	0.82%	11/10/2025 (Estimated)
SGRY Surgery Partners	-$168.10M	-$1.43	N/A	29.19	N/A	-5.57%	2.51%	1.01%	11/11/2025 (Estimated)

Latest SGRY, HIMS, GH, and RDNT Earnings

Date	Quarter	Company	Consensus Estimate	Reported EPS	Beat/Miss	Gap EPS	Revenue Estimate	Actual Revenue
8/10/2025	Q2 2025	RDNT RadNet	$0.17	$0.31	+$0.14	$0.43	$488.06 million	$498.23 million
8/5/2025	Q2 2025	SGRY Surgery Partners	$0.16	$0.17	+$0.01	-$0.02	$816.96 million	$826.20 million
8/4/2025	Q2 2025	HIMS Hims & Hers Health	$0.18	$0.17	-$0.01	$0.17	$550.06 million	$544.83 million
7/30/2025	Q2 2025	GH Guardant Health	-$0.52	-$0.44	+$0.08	-$0.80	$211.19 million	$232.09 million

Compare Dividends

Company	Annual Payout	Dividend Yield	3-Year Dividend Growth	Payout Ratio	Years of Consecutive Growth
GH Guardant Health	N/A	N/A	N/A	N/A	N/A
HIMS Hims & Hers Health	N/A	N/A	N/A	N/A	N/A
RDNT RadNet	N/A	N/A	N/A	N/A	N/A
SGRY Surgery Partners	N/A	N/A	N/A	N/A	N/A

Compare Debt

Company	Debt-to-Equity Ratio	Current Ratio	Quick Ratio
GH Guardant Health	N/A	3.71	3.35
HIMS Hims & Hers Health	1.72	4.98	4.46
RDNT RadNet	0.91	2.00	2.00
SGRY Surgery Partners	1.10	1.93	1.78

Compare Ownership

Institutional Ownership

Company	Institutional Ownership
GH Guardant Health	92.60%
HIMS Hims & Hers Health	63.52%
RDNT RadNet	77.90%
SGRY Surgery Partners	N/A

Insider Ownership

Company	Insider Ownership
GH Guardant Health	6.10%
HIMS Hims & Hers Health	13.71%
RDNT RadNet	5.60%
SGRY Surgery Partners	2.70%

Compare Miscellaneous Stats

Company	Employees	Shares Outstanding	Free Float	Optionable
GH Guardant Health	2,021	124.71 million	117.10 million	Not Optionable
HIMS Hims & Hers Health	1,637	226.02 million	195.03 million	Optionable
RDNT RadNet	11,021	76.92 million	72.61 million	Optionable
SGRY Surgery Partners	15,000	128.21 million	124.75 million	Optionable

SGRY, HIMS, GH, and RDNT Headlines

Recent News About These Companies

Surgery Partners, Inc. $SGRY Shares Purchased by Wellington Management Group LLP

August 23 at 5:39 AM | marketbeat.com

Vanguard Group Inc. Sells 451,691 Shares of Surgery Partners, Inc. $SGRY

August 23 at 3:35 AM | marketbeat.com

Surgery Partners, Inc. (NASDAQ:SGRY) Receives Average Rating of "Moderate Buy" from Brokerages

August 23 at 2:37 AM | marketbeat.com

Box, Intuitive Surgical, and Surgery Partners Stocks Trade Down, What You Need To Know

August 22 at 6:08 PM | msn.com

Invesco Ltd. Has $37.23 Million Holdings in Surgery Partners, Inc. $SGRY

August 20 at 3:42 AM | marketbeat.com

Surgery Partners, Inc. (NASDAQ:SGRY) Director Sells $455,209.32 in Stock

August 17, 2025 | marketbeat.com

Teresa Deluca Sells 20,018 Shares of Surgery Partners, Inc. (NASDAQ:SGRY) Stock

August 16, 2025 | insidertrades.com

Surgery Partners Announces Credit Agreement Amendment

August 15, 2025 | msn.com

Natixis Advisors LLC Takes Position in Surgery Partners, Inc. (NASDAQ:SGRY)

August 14, 2025 | marketbeat.com

The Top 5 Analyst Questions From Surgery Partners’s Q2 Earnings Call

August 13, 2025 | finance.yahoo.com

SGRY Q2 Deep Dive: Orthopedics and De Novo Expansion Drive Steady Growth

August 13, 2025 | msn.com

Surgery Partners, Inc. (NASDAQ:SGRY) Shares Sold by Headlands Technologies LLC

August 12, 2025 | marketbeat.com

Surgery Partners, Inc. (NASDAQ:SGRY) Shares Acquired by Covestor Ltd

August 10, 2025 | marketbeat.com

Wolverine Asset Management LLC Buys 43,336 Shares of Surgery Partners, Inc. (NASDAQ:SGRY)

August 10, 2025 | marketbeat.com

20,151 Shares in Surgery Partners, Inc. (NASDAQ:SGRY) Bought by XTX Topco Ltd

August 9, 2025 | marketbeat.com

Surgery Partners Appoints New Chairman After Resignation

August 8, 2025 | theglobeandmail.com

Surgery Partners Inc (SGRY) Q2 2025: Everything You Need To Know Ahead Of Earnings

August 6, 2025 | finance.yahoo.com

Surgery Partners, Inc. (NASDAQ:SGRY) Q2 2025 Earnings Call Transcript

August 6, 2025 | msn.com

Surgery Partners (NASDAQ:SGRY) Releases Quarterly Earnings Results, Beats Expectations By $0.01 EPS

August 6, 2025 | marketbeat.com

Surgery Partners (SGRY) Q2 Revenue Up 8%

August 6, 2025 | fool.com

Surgery Partners (NASDAQ:SGRY) Surprises With Q2 Sales

August 5, 2025 | finance.yahoo.com

New MarketBeat Followers Over Time

Media Sentiment Over Time

Top Headlines

View All

SGRY, HIMS, GH, and RDNT Company Descriptions

Guardant Health NASDAQ:GH

$61.40 +0.12 (+0.20%)

Closing price 08/22/2025 04:00 PM Eastern

Extended Trading

$61.30 -0.10 (-0.16%)

As of 08/22/2025 07:50 PM Eastern

Guardant Health, Inc., a precision oncology company, provides blood and tissue tests, data sets, and analytics in the United States and internationally. The company provides Guardant360; Guardant360 LDT; Guardant360 CDx Test; Guardant360 Response Test; Guardant360 TissueNext Test; GuardantINFINITY Test; GuardantConnect, an integrated software-based solution designed for clinical and biopharmaceutical customers to connect patients tested with assays with actionable alterations with potentially relevant clinical studies; GuardantOMNI Test for advanced stage cancer; and GuardantINFORM, an in-silico research platform for tumor evolution and treatment resistance across various biomarker-driven cancers. It offers Shield Test; Guardant Reveal Test for adjuvant treatment selection in early-stage cancer patients; Smart Liquid Biopsy Platform; and Guardant Galaxy, an AI-backed digital pathology platform that helps improve cancer biomarker detection. In addition, the company offers development services, including companion diagnostic development and regulatory approval, clinical study setup, monitoring and maintenance, testing development and support, technologies licensing, and kits fulfillment. The company has a collaboration agreement with Illumina, Inc. for the sharing of specimen samples to advance cancer research. The company was incorporated in 2011 and is headquartered in Palo Alto, California.

Hims & Hers Health NYSE:HIMS

$44.53 +0.57 (+1.30%)

Closing price 08/22/2025 03:59 PM Eastern

Extended Trading

$44.72 +0.19 (+0.42%)

As of 08/22/2025 08:00 PM Eastern

Hims & Hers Health, Inc. operates a telehealth consultation platform. It connects consumers to healthcare professionals, enabling them to access medical care for mental health, sexual health, dermatology and primary care. The company was founded in 2017 and is headquartered in San Francisco, CA.

RadNet NASDAQ:RDNT

$70.10 +1.49 (+2.17%)

Closing price 08/22/2025 04:00 PM Eastern

Extended Trading

$70.11 +0.02 (+0.02%)

As of 08/22/2025 06:54 PM Eastern

RadNet, Inc., together with its subsidiaries, provides outpatient diagnostic imaging services in the United States. The company operates in two segments: Imaging Centers and Artificial Intelligence. Its services include magnetic resonance imaging, computed tomography, positron emission tomography, nuclear medicine, mammography, ultrasound, diagnostic radiology, fluoroscopy, and other related procedures, as well as multi-modality imaging services. The company also develops and sells computerized systems that distribute, display, store, and retrieve digital images; offers picture archiving communications systems and related services; and develops and deploys AI suites to enhance radiologist interpretation of breast, lung, and prostate images, as well as AI solutions for prostate cancer screening. RadNet, Inc. was founded in 1981 and is headquartered in Los Angeles, California.

Surgery Partners NASDAQ:SGRY

$23.64 +0.78 (+3.41%)

Closing price 08/22/2025 04:00 PM Eastern

Extended Trading

$23.64 0.00 (0.00%)

As of 08/22/2025 04:10 PM Eastern

Surgery Partners, Inc., together with its subsidiaries, owns and operates a network of surgical facilities and ancillary services in the United States. The company provides ambulatory surgery centers and surgical hospitals that offer non-emergency surgical procedures in various specialties, including orthopedics and pain management, ophthalmology, gastroenterology, and general surgery. It offers diagnostic imaging, laboratory, obstetrics, oncology, pharmacy, physical therapy, and wound care; and ancillary services, including multi-specialty physician practices, urgent care facilities, and anesthesia services. In addition, it offers single- and multi-specialty facilities. Surgery Partners, Inc. was founded in 2004 and is headquartered in Brentwood, Tennessee.

More Stock Comparisions from MarketBeat

More Stock Ideas from MarketBeat

Stock Lists

Low Priced Stocks

Stocks By Exchange

Latest Stock Ideas

Get 30 Days of MarketBeat All Access for Free

Start Your 30-Day Trial

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Compare Stocks

Comparative Price Performance Over Time